drugset / Trial / NCT00713765

Pharmacokinetic Interaction Between AZD3480 and Donepezil

NCT00713765

Phase 1 Terminated 33 enrolled AstraZeneca
RandomizedCrossoverTriple-blindBasic science

Summary

The aims of this study are to 1) examine the effects of AZD3480 and donepezil on the blood concentrations of each other and 2) assess the safety and tolerability of the combined administration of AZD3480 with donepezil.

Timeline

Start
2008-12
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule Oral
Subject ispronicline Small molecule 40 mg Oral

Indications